Blackstone Inc’s Cidara Therapeutics CDTX Stock Holding History

Blackstone Inc’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,944	Closed	-$1.53M	–	424
2025 Q4	$1.53M	Buy	+6,944	New	+$1.12M	0.01%	204

Blackstone Inc's CDTX Position: Q1 2026 in Review

Blackstone Inc sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 6,944 shares — an estimated $1.53M sold.

Blackstone Inc first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.53M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Blackstone Inc reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Blackstone Inc sold 6,944 Cidara Therapeutics shares in Q1 2026, an estimated $1.53M.
Blackstone Inc first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Blackstone Inc's Cidara Therapeutics position peaked at $1.53M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.